Vascular Subphenotypes of Lung Disease in HIV & COPD (VAST)
This study is currently recruiting participants.
Verified April 2012 by University of Pittsburgh
Sponsor:
University of Pittsburgh
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01581086
First received: April 17, 2012
Last updated: April 19, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130305102838im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
This study is looking for high blood pressure in the lungs (Pulmonary artery hypertension PAH) in HIV and COPD patients.
Condition |
---|
Pulmonary Artery Hypertension |
Study Type: | Observational |
Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
Official Title: | Identify and Characterize Populations at Risk for Developing Pulmonary Arterial Hypertension (PAH) |
Resource links provided by NLM:
Further study details as provided by University of Pittsburgh:
![](https://webarchive.library.unt.edu/web/20130305102838im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
Pitt mens Study(MACS).
University of Pittsburgh HIV Clinic(PACT).
Emphysema COPD Research Center Research Registry(ECRC).
Criteria
Inclusion Criteria:
- Male/Female 18-80 years of age.
- Subject has been previously enrolled in PACT/MAC/ECRC study.
- Must have recent ProBNP test >120pg/ml or abnormal echocardiogram (right ventricular systolic pressure >or=40mmHg) without evidence of left sided heart failure.
Exclusion Criteria:
- Previous diagnosis of congenital heart failure.
- If evidence of Left ventricular systolic or diastolic dysfunction, echo will be reviewed by the PI on a case by case basis.
- Creatine clearance <60ml/min per 1.73 m2.
- Undiagnosed chest pain or myocardial infarction, stroke or cardiovascular event within 3 months.
- Pregnancy.
- Subjects receiving chronic anticoagulant.
- Inability to complete the 6 minute walk test.
![](https://webarchive.library.unt.edu/web/20130305102838im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Please refer to this study by its ClinicalTrials.gov identifier: NCT01581086
Contacts
Contact: Tammi F Lawther, BS | 412-624-8295 | lawthertf@upmc.edu |
Locations
United States, Pennsylvania | |
University of Pittsburgh | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 |
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: | Hunter C Champion, MD | University of Pittsburgh |
![](https://webarchive.library.unt.edu/web/20130305102838im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
No publications provided
Responsible Party: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT01581086 History of Changes |
Other Study ID Numbers: | VAST11060550 |
Study First Received: | April 17, 2012 |
Last Updated: | April 19, 2012 |
Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on March 03, 2013